Furthermore, our identification of CELF4 as a fibromyalgia risk locus provides a direct genetic rationale for exploring CELF4-based gene therapies – already under investigation for chronic pain – for fibromyalgia in particular. Here, CELF4 is linked to fibromyalgia.